Podcasts about mease

This week, we explore a groundbreaking study on the prevalence of fibromyalgia and widespread pain in patients with psoriatic arthritis with first author and ACR Master, Dr. Philip J. Mease. In his latest article, titled: Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association with Disease Severity Assessment in a Large US RegistryUID , Dr. Mease explains what the presence of these conditions reveals about disease severity and how they converge. 

Master rheumatologist, Dr. Philip J. Mease, joins us for a deep dive into psoriatic arthritis (PsA). Dr. Mease explains how to diagnose PsA in patients, the latest treatments, his insights on evaluating joint pain, the role of enthesitis and axial involvement and how to differentiate between inflammatory and non-inflammatory causes of joint pain in those with PsA. This was an enlightening discussion with a master physician that we know you'll enjoy! 

As the curtains draw close on the fantastical production of "Seussical" at Theatre Harrisburg, audiences are left enchanted by the whimsical world of Dr. Seuss characters brought to life on stage. Since its opening on April 26th, the musical has captivated hearts and minds with its tale of friendship, loyalty, and community. In an exclusive interview with Lorien Reese Mahay, the Executive Director of Theatre Harrisburg, and Becky Mease, the chair of the board of Directors, insights were shared on the success of the season and the compelling reasons why theater enthusiasts should seize the opportunity to witness the magic of "Seussical" before it bids adieu. "The response to 'Seussical' has been overwhelmingly positive," Mahay beams, reflecting on the journey of Horton the Elephant as he embarks on a daring adventure to safeguard Jojo and the Whos. "It's a testament to the enduring appeal of Dr. Seuss's timeless characters and themes." Mease echoes this sentiment, emphasizing the profound resonance of the production's themes of friendship, loyalty, and community. "In a world filled with challenges, 'Seussical' reminds us of the importance of standing together and supporting one another," she asserts. Adapted from Dr. Seuss's beloved stories, "Seussical" follows Horton's quest to protect the Whos, encountering trials and tribulations along the way. From facing ridicule to braving danger, Horton's unwavering dedication is a poignant reminder of the power of perseverance. "Seussical" not only delights audiences with its vibrant performances but also provides a platform for creative expression through its inventive set designs, lighting, and costumes. The musical's alternate orchestration offers a fresh take, catering to diverse interpretations of the beloved characters. With its universal appeal and family-friendly charm, "Seussical" promises an unforgettable theatrical experience for audiences of all ages. As the final performances approach, Mahay and Mease extend a heartfelt invitation for theater enthusiasts to immerse themselves in the enchanting world of Dr. Seuss one last time. And as the curtain falls on "Seussical," Theatre Harrisburg leaves an indelible mark on its audience, reminding them of the enduring power of imagination, friendship, and the triumph of the human spirit.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Rebecca Schillack and Kathleen Mease discuss how attending HELIX, the annual conference celebrating high expectations for students with low incidence disabilities, impacted their efforts to support English language learners with disabilities. Rebecca and Kathleen attended the 2023 HELIX conference as part of a team from Bensalem Township School District through a conference program promoting cross-department and cross-agency collaboration. HELIX conference: https://www.pattan.net/Training/Conferences/HELIX-Conference Miss Schillack is a Special Education teacher at Bensalem Township School District teaching students, within the Life Skills program, Functional Language Arts and Reading Strategies. Miss Schillack has worked as a Special Education Teacher for the Bensalem Township School District for 15+ years. She co-teaches a class with Ms. Mease, the English Foundations' teacher at Bensalem High School. The class includes students that have English language needs in addition to their individual disabilities. Kathleen Mease is an ELD teacher from Bensalem High School. She primarily teaches newcomer English Language Learners, but also co-teaches ELLs who are within the Life Skills program. She works closely with a Life Skills teacher to help these students with reading strategies. Visit our website at http://www.pattan.net

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZQX865. CME credit will be available until November 2, 2024.Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care Clinician in Multidisciplinary CarePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresPhilip J. Mease, MD, MACR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie; ACELYRIN Inc.; Aclaris Therapeutics, Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Galapagos NV; Gilead Sciences, Inc.; GlaxoSmithKline; Inmagene; Janssen Pharmaceuticals, Inc.; Lilly; MoonLake Immunotherapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB, Inc.; Ventyx Biosciences, Inc.; and XinThera.Grant/Research Support from AbbVie.; ACELYRIN Inc.; Amgen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sun Pharmaceutical Industries Ltd.; and UCB, Inc.Speaker for AbbVie; Amgen; Janssen Pharmaceuticals, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and UCB, Inc.M.E. Beth Smith, DO, MCR, FACP, has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.

Where does OT fit in psoriatic arthritis (PsA) care? In this one hour course we'll dive into a comprehensive guideline for psoriatic arthritis treatment, which recommends patients utilize a mix of non-pharmacological tools, like occupational therapy. This article will help you brush up on psoriatic arthritis, see OT within a holistic approach to care, and appreciate the importance of individualized care (which we are so skilled in providing). After we review the article, we'll be joined by  Duana Russell-Thomas, OTD, OTR/L, to discuss her innovative approach to arthritis care through a self-management program—and the funding that makes this possible. Her story—and this guideline—will leave you with practical takeaways for improving your care of PsA. In order to earn credit for this course, you must take the test within the OT Potential Club.You can find more details on this course here:https://otpotential.com/ceu-podcast-courses/ot-and-psoriatic-arthritisLearn more about our guest:https://otpotential.com/occupational-therapy-directory/duana-Here's the primary research we are discussing:Singh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J., Husni, M. E., Kenny, S., Kwan-Morley, J., Lin, J., Marchetta, P., Mease, P. J., Merola, J. F., Miner, J., Ritchlin, C. T., Siaton, B., Smith, B. J., … Reston, J. (2018). 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Journal of Psoriasis and Psoriatic Arthritis, 4(1), 31–58.Support the show

When someone gets involved in the drug trade, violence usually isn't far behind. It's a dangerous path to tread where survival can hinge almost entirely upon alliances. If you piss off the wrong person, you might pay with your life. In the late 1980s, Missouri native Darrell Mease encountered an opportunity he couldn't turn down. The 42-year-old carpenter was hired by Lloyd Lawrence, who happened to be a kingpin in a local methamphetamine ring. Instead of considering the danger he might face, Mease was blinded by dollar signs. This chance encounter set Mease's life on a deeply violent trajectory. It would escalate into an extreme act of revenge outside a serene cabin in the Ozark mountains where an entire family would be murdered. Follow Jami on Instagram & TikTok @JamiOnAir and join the Serial Streamers true crime TV club! Sponsors HelloFresh: HelloFresh.com/MURDERISH50 - use code MURDERISH50 for 50% off + free shipping. Rocket Money: RocketMoney.com/MURDERISH to easily cancel unwanted subscriptions. ZocDoc: ZocDoc.com/MURDERISH, then download the free app & book a top-rated doctor. CrimeCon 2023: Visit CrimeCon.com and use code MURDERISH for 10% off a Standard Badge. Dirty Money Moves: Women in White Collar Crime - Listen on Apple Podcasts https://podcasts.apple.com/us/podcast/dirty-money-moves-women-in-white-collar-crime/id1619521092. TrendVETTERS: Listen on Apple Podcasts https://podcasts.apple.com/us/podcast/trendvetters/id1682586524. Want to advertise on this show? We've partnered with Cloud10 Media to handle our advertising requests. If you're interested in advertising on MURDERISH, send an email to Sahiba Krieger mailto:sahiba@cloud10.fm with a copy to mailto:jami@murderish.com.  Research & Writing: Alison Schwartz. Visit Murderish.com for more info about the show and Creator/Host, Jami, as well as a list of sources for this episode.  Ad-Free episodes: Visit https://www.patreon.com/Murderish to join MURDERISH | Behind the Mic and get access to bonus episodes, ad-free episodes, and other cool perks. Listening to this podcast doesn't make you a murderer, it just means you're murder..ish. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jazz Dance Fusion Specialwith Guest Paul Mease Measom

Introducing Stuart Mease Hey, everyone! Welcome back to another episode of Leaving The Nest. I'm your host, Kathleen Pellegrino, from ROCS Grad Staffing. Our mission is to help you find a job out of college and thrive in the real world.  As we continue to move further into the new year of 2023 and the post-pandemic era, it has become increasingly apparent that there have been significant shifts in the realm of college recruiting and staffing.  With the rapidly evolving nature of the job market, companies and job seekers must stay updated on the latest trends to stay competitive. ROCS is increasing our staff and expanding our markets to help clients and candidates navigate these dynamic and evolving times. Today, I have Stuart Mease with me, who has recently joined the ROCS team as the Director of North Carolina Operations. With a wealth of experience in the private, government and higher education sectors, Stuart brings with him a deep passion for helping recent graduates connect with employers. I'm excited to have him on the show so our listeners can learn more about his story as he shares his knowledge with us. Thanks again for listening to Leaving The Nest! Be sure to leave us a review wherever you are listening and to share this episode with others you know who are just leaving the nest! Enjoy my conversation with Stuart!   In This Episode: [2:13] - We're introduced to our guest, Stuart Mease.  [4:32] - Stuart shares the reasoning behind his sports analogies.  [5:14] - We hear about Stuart's experience "Leaving the Nest." [5:46] - Stuart shares how his educational foundation and experience prepared him for his role as the Director of North Carolina Operations for ROCS.  [8:28] - How seeing young people struggle to select a valuable educational path fueled Stuart's passion for college recruiting.    [09:59] - Stuart recounts the origin of the reverse job fair at Virginia Tech, where students were the ones in the booths rather than employers. [13:25] - Stuart offers his perspective on how important it is for students to make informed decisions about their majors, increase their chances for success (and decrease their chances of being underemployed). [17:20] - How guidance from people who have already navigated the college major selection process can be incredibly valuable for those currently making the same choices. [18:19] - Stuart reflects on his time at Virginia Tech.  [23:12] - Stuart recounts the amusing story of his first meeting with Tom and Brandon of ROCS. [27:26] - The delight in witnessing the achievements of those we have known for a long time. For Stuart, this is especially true for the students he works with.  [29:12] - Stuart shares the behind-the-scenes of his move into the staffing industry and the crucial knowledge he has acquired during the process. [30:38] The three main areas Stuart is focused on for growth at ROCS. [32:02] -The post-pandemic disruption in college recruiting and how he's using his position at ROCS to help level the playing field for small and medium-sized businesses.   [34:18] - How ROCS is uniquely positioned to help clients and candidates navigate these dynamic and evolving times. [36:42] - Stuart shares his interests outside of work. [37:59] - Sharing some of his favorite ROCS memories so far, Stuart recounts his experiences and shares why everyone loves it when he visits the ROCS HQ. [41:18] - Stuart lets us know how we can connect with him, and Kathleen wraps up the conversation.  Resources: ROCS Grad Staffing Listen to Leaving The Nest Podcast    Connect with Kathleen: kathleen@rocsjobs.com LinkedIn  Call: 703-579-6677   Connect with Stuart: stuart@rocsjobs.com LinkedIn

Hello and welcome back to the latest ThisIsTheMusic meets Podcast. For  the latest episiode, we were joined Derby indie rocknball  @TheMeaseBand    On the latest podcast we discussed bands latest single "High Definition  (You Ain't Seen Nothin"),  the recording process of their explosive  debut album "The World In High Definition", 2022 highlights, the return  of live music and a chat about their respective football teams!  You can follow The Mease across all social media platforms  @TheMeaseBand    High Definition (You Ain't Seen Nothin) is out now across all  streaming/download platforms.   For upcoming gig information and the link to the bands bandcamp store to  buy their debut album "The World in High Definition" Click the link  below https://linktr.ee/Themease Please subscribe so you never miss a   @ThisIsTheMusic_  meets podcast. It would be great if you could leave a  review and provide a 5-star rating as it really helps the bands we  interview to get discovered.  Click the link below to find out more about ThisIsTheMusic!! https://linktr.ee/ThisIsTheMusic_

Missed our latest show? The 2 hour show is now available to listen to again in all its glory. In running order we played: Gallahers Green; Rosa Caelum; The Malakites; Hazy Sundays;Bad Athlete; ThisIsWar; Mantra Ray (Ft Joe Adhemar); The Mease; Dirty Blonde; Basic State; The Public Eye; Jay Tennant; San Quentin; Darlings; The Keepers; New Town; The Lucky Doves; Shambolics; Maze; Boxteles; Marseille; Hippy; The Rivers; Columbia; The Window View; Lock-In; 

Hello and welcome to  this special edition of the ThisIsTheMusic Rise of The Indie Artist show. Over the course of our final show of 2022, we played some of our favourite tracks from the year. The Heavy North; Spangled; Lock-IN; San Quentin; The Public Eye; The Shed Project; Marseille; Ben Wal;ker; Jay Tenannant; Lissy Taylor; Maystones; Pastel; Skylights; Shader; Rolla; Columbia; The Mease; The Howlers; The Clause; Pacifica; The Chase; Haxy Sundays; Holy Coves; Cavalcade; Civic Green; Happy Christmas! 

Our series featuring falconers from the UK concludes with it's seventeenth installment, which features John Mease. John is known in the UK for hunting with golden eagles, and is one of the few currently employed to do so as well! His story of how he has dedicated his life to falconry and ended up in his position hunting with eagles professionally is one you can't miss! We'd like to once again send a very special thank you to Simon Tyers and Neil Davies for helping to make this series happen. Without them, it definitely wouldn't have! Please head to http://www.thespecialistfalcon.com and http://pursuitfalconry.co.uk and check out their respective book and publication if you haven't yet, they're well worth it!

Our series featuring falconers from the UK concludes with it's seventeenth installment, which features John Mease. John is known in the UK for hunting with golden eagles, and is one of the few currently employed to do so as well! His story of how he has dedicated his life to falconry and ended up in his position hunting with eagles professionally is one you can't miss! We'd like to once again send a very special thank you to Simon Tyers and Neil Davies for helping to make this series happen. Without them, it definitely wouldn't have! Please head to http://www.thespecialistfalcon.com and http://pursuitfalconry.co.uk and check out their respective book and publication if you haven't yet, they're well worth it! Special thanks to the organizations and businesses who've kindly helped support the podcast!The Archives of Falconryhttp://www.falconry.orgMarshall Radio Telemetryhttp://www.marshallradio.comMasters of the Skieshttp://www.mastersoftheskies.orgBaba Yaga Craftshttp://www.instagram.com/babayagagoshawkNorth Mountain Goshawkshttp://www.northmountaingoshawks.comNew Mexico Falconers AssociationArizona Falconers Assocationhttp://www.arizonafalconers.comTexas Hawking Associationhttp://www.texashawking.orgNorth American Falconers Associationhttp://www.n-a-f-a.comFalconry Fundhttp://www.falconryfund.orgPursuit Falconry and Conservation Magazinehttp://pursuitfalconry.co.ukThe Specialist Falconhttp://www.thespecialistfalcon.comCape Falconry Clubhttp://www.capefalconry.co.za

Kurtis Powers kicks off the 1st broadcast of Side Effects with a bang! Classics from The Stone Roses, New Order, The Charlatans, Ride, Dodgy, The Stereo MCs, and more.Plus, new music from Pastel, Afflecks Palace, Alvvays, The Mease, Hazel English, and more!This show was first broadcast on the 5th of December, 2022For more info and tracklisting, visit https://thefaceradio.com/side-effects/.Tune into new broadcasts of Side Effects, LIVE, Monday from 12 - 2 PM EST / 5 - 7 PM GMT on The Face Radio.Dig this show? Please consider supporting The Face Radio: http://support.thefaceradio.com.Facebook: https://www.facebook.com/KurtisPowersInstagram: https://www.instagram.com/kurtispowersMixcloud: https://www.mixcloud.com/KurtisPowers/Soundcloud: https://soundcloud.com/kurtispowersTwitter: https://twitter.com/kurtispowersEmail: kurtis@thefaceradio.com Support The Face Radio with PatreonSupport this show http://supporter.acast.com/thefaceradio. Hosted on Acast. See acast.com/privacy for more information.

Are you a female entrepreneur wondering how to bring your passion and training and integrate it into your everyday life? Are you okay with having an ebb and flow in your work/life balance? On this week's Wellness and Wealth podcast, Cheyenne Mease of Health Heart Soul LLC shares what it looks like to go from a challenging, always-on-the-go schedule of Mom, Caretaker, Employee, and Volunteering to one of flexibility. In addition, this episode will cover how she uses a color-coded calendar system to help her see if things are getting off balance. In this episode, Cheyenne Mease answers the following questions: What is an integrated schedule? How do you accept that you may not get it all done? How do you stop feeling guilty when you can't self-care? How do you know if you are heading into burnout?  What is a practical way to get started setting boundaries?   Connect with Wendy Manganaro: Website: www.wendymanganaro.com Our Services: Mindful Marketing Strategies LinkedIn: https://www.linkedin.com/in/wendymanganaro1/ Mindset & Marketing: What's Keeping You Blocked PDF

Missed our live show? Then you can dig right into the replay! Over the 2 hour show we played: Pastel; The Skinner Brothers; The Heavy North; Paytron Saint; Laurie Wright; Callum Gibson; Duncan Cassidy; Nick Shane; Joe Wright (Exclusive 1st play of their forthcoming new single); Wez King; The Shed Project; Stanleys; Gallahers Green (Exclusive 1st play of forthcoming new single); Under One Sun; Aerial Salad; Albion; Marseille; The Mease; The Malakites; The Vonics; Mvnich (Exckusive 1st play of their forthcoming new single); The Great Leslie; Neon Listen; Black Market Karama; San Quentin; Lock-In; Follow ThisIsTheMusic: Twitter @ThisIsTheMusic2 Instagram @ThisIsTheMusic Facebook @ThisisTheMusic Web www.thisisthemusic.com Don't forget to hit that subscribe button to receive the latest radio shows and podcasts direct to your preferred podcast listenting service!!

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.08.30.505868v1?rss=1 Authors: Martin-Cortecero, J., Isaias-Camacho, E. U., Boztepe, B., Ziegler, K., Mease, R. A., Groh, A. Abstract: Most brain circuits comprise intermingled neuronal populations with heterogeneous input and output connectivity, which limits the ability to unambiguously map how the circuit of interest synaptically links specific input pathways to specific downstream targets. By applying newly available transsynaptic and intersectional tracing tools to investigate input-output connectivity of the superior colliculus (SC), a conserved midbrain-node with extensive long-range connectivity throughout the brain, we identify hitherto unknown connectivity features underlying cortical control of SC sensory-motor transformations. We pinpoint a whisker region in the SC of mice as a node for the integration of somatosensory and motor cortical signals. Tracing input-defined pathways from brainstem, motor- and somatosensory cortices to the whisker SC and further on to collicular downstream targets in the midbrain and brainstem revealed that long-range inputs establish synaptic contacts with inhibitory and excitatory SC-output neurons, thereby providing monosynaptic trans-collicular pathways between specific cortical and subcortical circuits for somato-motor integration. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

The author/photographer has written a new book as the Champlain Valley Fair gets ready to celebrate 100 years.

Joe shares how because of his rental income he's able to be selective with freelance work he takes on for his 9 - 5 job. He only takes on projects that he will enjoy doing, instead of taking on whatever he can for the money.Joe shares his gross rental income, mortgage payment amounts, typical expenses, and his net monthly cash flow.We also talk about how he got started buying rentals, and why he likes buying both long-term rentals and Airbnb's.https://rentalincomepodcast.com/episode379

In 1988, a Stone County grandfather, grandmother, and their 19-year old grandson were gunned down in a gruesome killing. Investigators said it was one of the most disturbing crime scenes they had ever witnessed. Law enforcement, and loved ones of Lloyd, Frankie, and Willie Lawrence, were left with a major question: who would brutally murder this family out for a Sunday ride on their four-wheelers?

The brothers are back with professional Dungeon Master and owner of Red Dragon's Hoard game shop in Niagara Falls, Rich Mease!Red Dragon's Hoard: https://www.reddragonshoard.com/?gclid=CjwKCAiAsNKQBhAPEiwAB-I5zbCauWPWPcnm0yzMUXguzi3P2KTIp54MQzG5iOO18WrhYclHot5UqBoCK8YQAvD_BwEMerch Link: https://snack-spot-se.creator-spring.comInstacart Link: https://instacart.oloiyb.net/vAWXNTITC Instagram: https://www.instagram.com/twointhecooler/?hl=enSupport the show (https://teespring.com/stores/two-in-the-cooler)

Last week, Janssen announced results from a network meta-analysis (NMA) that showed that the biologic therapy guselkumab ranked highest for overall level of skin clearance. The NMA involved 33 phase 3 randomized clinical trials and 15 different targeted therapies including risakinumab and more. Philip J. Mease, MD, director of rheumatology research at the Swedish Rheumatology Research Group, spoke of how the biologic distinguished itself from other targeted therapies in the network meta-analyses, and how these kinds of analyses could aid physicians in treating patients affected by psoriasis.

"If there is anything that I've seen transformed in the past 19 months, is that more and more people are unwilling to accept what we previously accepted as normal."- Yuan WangIn this episode, our featured voices are the co-founder and director of Blue Heart Lindley, Mease and co-director of a APIENC Yuan Wang.This episode is focused on sharing the work of two grassroots organizations Blue Heart which empowers individual funders through their efforts of identifying and funding under resourced organizations such as APINK who works with our Asian American and Pacific Islander Trans, Queer & working class BIPOC [Black Indigenous and People of Color] community members.To become a member, volunteer and fund Blue Heart's work please go to blue heart action dot org.  To find out more and support APIENC's work with our Asian American and Pacific Islander Trans, Queer and working class BIPOC [Black Indigenous and People of Color] community members go to APIENC dot org.Please consider donating to Voices of the Community - Voices of the Community is now fiscally sponsored by Intersection for the Arts, a 501(c)(3) nonprofit organization, which allows us to offer you tax deductions for your contributions. Please consider making a donation to help us provide future shows just like this one.

In 1988, a Stone County grandfather, grandmother, and their 19-year old grandson were gunned down in a gruesome killing. Investigators said it was one of the most disturbing crime scenes they had ever witnessed. Law enforcement, and loved ones of Lloyd, Frankie, and Willie Lawrence, were left with a major question: who would brutally murder this family out for a Sunday ride on their four-wheelers?

Go online to PeerView.com/JTZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the recognition and management of axial spondyloarthritis (axSpA). Upon completion of this accredited CE activity, participants should be better able to: Describe axial spondyloarthritis (axSpA) pathophysiology and epidemiology and complications associated with diagnostic and treatment delays, Identify axSpA in patients with inflammatory back pain via assessment of medical history, musculoskeletal symptoms and findings, and extra-articular manifestations and comorbidities, Assess efficacy and safety data related to novel treatment options for axSpA, recognizing the potential clinical impact on the management of patients who do not respond well to traditional pharmacologic therapies, Employ treatment plans for individual patients with axSpA in accordance with current evidence, expert recommendations, and patient needs and preferences, Recognize the importance of collaborating with rheumatologists to provide optimal treatment and longitudinal support for patients with axSpA.

Go online to PeerView.com/JTZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the recognition and management of axial spondyloarthritis (axSpA). Upon completion of this accredited CE activity, participants should be better able to: Describe axial spondyloarthritis (axSpA) pathophysiology and epidemiology and complications associated with diagnostic and treatment delays, Identify axSpA in patients with inflammatory back pain via assessment of medical history, musculoskeletal symptoms and findings, and extra-articular manifestations and comorbidities, Assess efficacy and safety data related to novel treatment options for axSpA, recognizing the potential clinical impact on the management of patients who do not respond well to traditional pharmacologic therapies, Employ treatment plans for individual patients with axSpA in accordance with current evidence, expert recommendations, and patient needs and preferences, Recognize the importance of collaborating with rheumatologists to provide optimal treatment and longitudinal support for patients with axSpA.

Go online to PeerView.com/JTZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the recognition and management of axial spondyloarthritis (axSpA). Upon completion of this accredited CE activity, participants should be better able to: Describe axial spondyloarthritis (axSpA) pathophysiology and epidemiology and complications associated with diagnostic and treatment delays, Identify axSpA in patients with inflammatory back pain via assessment of medical history, musculoskeletal symptoms and findings, and extra-articular manifestations and comorbidities, Assess efficacy and safety data related to novel treatment options for axSpA, recognizing the potential clinical impact on the management of patients who do not respond well to traditional pharmacologic therapies, Employ treatment plans for individual patients with axSpA in accordance with current evidence, expert recommendations, and patient needs and preferences, Recognize the importance of collaborating with rheumatologists to provide optimal treatment and longitudinal support for patients with axSpA.

Go online to PeerView.com/JTZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the recognition and management of axial spondyloarthritis (axSpA). Upon completion of this accredited CE activity, participants should be better able to: Describe axial spondyloarthritis (axSpA) pathophysiology and epidemiology and complications associated with diagnostic and treatment delays, Identify axSpA in patients with inflammatory back pain via assessment of medical history, musculoskeletal symptoms and findings, and extra-articular manifestations and comorbidities, Assess efficacy and safety data related to novel treatment options for axSpA, recognizing the potential clinical impact on the management of patients who do not respond well to traditional pharmacologic therapies, Employ treatment plans for individual patients with axSpA in accordance with current evidence, expert recommendations, and patient needs and preferences, Recognize the importance of collaborating with rheumatologists to provide optimal treatment and longitudinal support for patients with axSpA.

Go online to PeerView.com/JTZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the recognition and management of axial spondyloarthritis (axSpA). Upon completion of this accredited CE activity, participants should be better able to: Describe axial spondyloarthritis (axSpA) pathophysiology and epidemiology and complications associated with diagnostic and treatment delays, Identify axSpA in patients with inflammatory back pain via assessment of medical history, musculoskeletal symptoms and findings, and extra-articular manifestations and comorbidities, Assess efficacy and safety data related to novel treatment options for axSpA, recognizing the potential clinical impact on the management of patients who do not respond well to traditional pharmacologic therapies, Employ treatment plans for individual patients with axSpA in accordance with current evidence, expert recommendations, and patient needs and preferences, Recognize the importance of collaborating with rheumatologists to provide optimal treatment and longitudinal support for patients with axSpA.

Go online to PeerView.com/JTZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the recognition and management of axial spondyloarthritis (axSpA). Upon completion of this accredited CE activity, participants should be better able to: Describe axial spondyloarthritis (axSpA) pathophysiology and epidemiology and complications associated with diagnostic and treatment delays, Identify axSpA in patients with inflammatory back pain via assessment of medical history, musculoskeletal symptoms and findings, and extra-articular manifestations and comorbidities, Assess efficacy and safety data related to novel treatment options for axSpA, recognizing the potential clinical impact on the management of patients who do not respond well to traditional pharmacologic therapies, Employ treatment plans for individual patients with axSpA in accordance with current evidence, expert recommendations, and patient needs and preferences, Recognize the importance of collaborating with rheumatologists to provide optimal treatment and longitudinal support for patients with axSpA.

The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist. Included are excerpts from this month's Editor's Picks spotlight interview with authors Mary Safy-Khan, Paco Welsing and Johannes Jacobs from Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, The Netherlands about their and their co-authors' article "Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use". - https://doi.org/10.3899/jrheum.200213 This month's selections also include: Mease, et al: Comparison of Men and Women With Axial Spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry - https://doi.org/10.3899/jrheum.201549 Feher, et al: Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography/Computed Tomography in Patients With Systemic Sclerosis - https://doi.org/10.3899/jrheum.210040 Mohajer, et al: Metabolic Syndrome and Osteoarthritis Distribution in the Hand Joints: A Propensity Score Matching Analysis From the Osteoarthritis Initiative - https://doi.org/10.3899/jrheum.210189 Fernández-Ávila, et al: Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America - https://doi.org/10.3899/jrheum.201623 Gilvaz et al: A Case of Disseminated Cutaneous Mycobacterium chelonae Infection During Treatment With Tofacitinib - https://doi.org/10.3899/jrheum.200730 Jansen, et al: Smoking and Methotrexate Inefficacy in Rheumatoid Arthritis: What About Underlying Molecular Mechanisms? - https://doi.org/10.3899/jrheum.210217 Leung: Gender Differences in Disease Activity and Impact in Axial Spondyloarthritis - https://doi.org/10.3899/jrheum.210564 To read these, and other full articles visit www.jrheum.org. Music by David Hilowitz

Philip Mease, Professor at the University of Washington School of Medicine in Seattle. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Mease discusses the longer-term safety and maintenance of efficacy of upadacitinib in patients with RA.

Lead author, Dr. Philip Mease, MD, Director of Rheumatology Research at the Swedish Medical Center/Providence St. Joseph Health and Clinical Professor at the University of Washington School of Medicine, discusses new data from the Phase 3 DISCOVER-1 and DISCOVER-2 studies published in "The Lancet Rheumatology" (July 2021) on the efficacy of guselkumab on axial symptoms in patients with active psoriatic arthritis. Up to 70% of PsA patients experience axial symptoms. #TREMFYA #PsoriaticArthritis Philip J Mease, MD, is a Clinical Professor at the University of Washington School of Medicine and Director of Rheumatology Research at the Swedish Medical Center in Seattle, WA. Dr Mease's clinical practice is based at Seattle Rheumatology Associates. He received his undergraduate and medical degrees at Stanford University Medical School, and he completed his residency in internal medicine at the University of Washington's School of Medicine, where he also served as chief resident and fellow in rheumatology. Dr Mease conducts clinical trials on emerging therapies for rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, osteoarthritis, and lupus. He also conducts research in disease state metrics and is the co-chair of three working groups for OMERACT (Outcome Measures in Rheumatology Clinical Trials) on psoriatic arthritis, fibromyalgia, and single-joint assessment, as well as a member of the Soluble Biomarker working group. Dr Mease is a founding organizer and President of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), a member of SPARTAN (Spondyloarthritis Research & Treatment Network), and a member of TREG (The Rheumatology Education Group). He has published 18 book chapters and nearly 400 journal articles.

Today we celebrate a happy lyricist and poet. We'll also remember a charming diary entry from 1938 by a Canadian conservationist and naturalist. We’ll honor a poem by Walt Whitman that inspired a beautiful composition that premiered this day in 1946. We hear an excerpt about the healing power of the garden. We Grow That Garden Library™ with a gorgeous book about Wave Hill garden in the Bronx. And then we’ll wrap things up with a little story about the origin of ketchup.   Subscribe Apple | Google | Spotify | Stitcher | iHeart To listen to the show while you're at home, just ask Alexa or Google to “Play the latest episode of The Daily Gardener Podcast.” And she will. It's just that easy.   The Daily Gardener Friday Newsletter Sign up for the FREE Friday Newsletter featuring: A personal update from me Garden-related items for your calendar The Grow That Garden Library™ featured books for the week Gardener gift ideas Garden-inspired recipes Exclusive updates regarding the show Plus, each week, one lucky subscriber wins a book from the Grow That Garden Library™ bookshelf.   Gardener Greetings Send your garden pics, stories, birthday wishes, and so forth to Jennifer@theDailyGardener.org   Curated News Sloping Garden Ideas | Ideal Home | Tamara Kelly   Facebook Group If you'd like to check out my curated news articles and original blog posts for yourself, you're in luck. I share all of it with the Listener Community in the Free Facebook Group - The Daily Gardener Community. So, there’s no need to take notes or search for links. The next time you're on Facebook, search for Daily Gardener Community, where you’d search for a friend... and request to join. I'd love to meet you in the group.   Important Events May 14, 1840 Today is the birthday of the American poet, lyricist, and hymn-writer George Cooper. Today, George is remembered for his happy song lyrics, which were often set to music written by Stephen Foster. And George wrote a little poem dear to gardeners called, My Garden. When fields are green, and skies are fair, And summer fragrance fills the air, I love to watch the budding rose That in my pleasant garden grows; But when old Winter, fierce and free, Has hushed the murmur of the bee, And all the fields and hills are hid Beneath his snowy coverlid, Oh! then my only garden-spot Is just this little flower pot.   May 14, 1938 On this day, the Canadian conservationist and naturalist Charles Joseph Sauriol wrote in his journal, “I have some most beautiful Pansies from the seeds of last year. Pansies are a surprise packet. You never know what to expect, and you are never disappointed if you [don't?] expect much."  We found on Thursday night a section of Pine root with a Dogwood growing from its wood and rotted mold. Transplanted it to the Wild Flower garden. It will be exactly what I will require for certain Wild Flowers. Planted a Bleeding Heart. Have wanted to do so for several years. It's an old-fashioned flower. Mother always used to have one in her garden when I was a small boy.” Bleeding heart is in the poppy family. Additional common names for  Bleeding heart include “lyre flower” and “lady-in-a-bath.” Native to Siberia, northern Asia, and North America, there are several cultivars for gardeners to consider, including ‘Alba,’ which has white flowers, ‘Gold Heart,’ which has yellow leaves; and  ‘Valentine,’ which has red-and-white blossoms. Auntie Dogma’s Garden Spot blog says, “No other plant bears perfect heart-shaped flowers like those of the Bleeding Heart. If you press the flowers between the pages of a heavy book, you’ll have papery-thin little hearts to adorn letters or valentines. If you turn a flower upside down and pull the two halves apart, you’ll see a lady in a pink bathtub, or perhaps you’ll see a white lyre with strings of silk.” And then, she shares the interactive story of the bleeding heart that uses a blossom to tell the story. “(To begin narration of the story, hold a heart blossom in the palm of your hand.) Long ago, there lived a noble prince who tried in vain to win the heart of a very beautiful princess. The prince had brought the princess wonderful gifts from his travels far and wide. Yet, she had taken no notice of him. One day the prince returned from a long journey with very special gifts to surely win the love of the princess. First, he presented her with two magical pink bunnies.  (Peel off the two outer petals and set them on their sides to display two little pink bunnies.) The princess only sighed and barely looked at the little bunnies. The hopeful prince had one more gift saved for last – he presented a pair of beautiful enchanted earrings. (Remove the two long white petals and hold them next to your ears.) Again, the princess hardly noticed the prince’s gift. Now the poor prince was utterly heartbroken. He could try no more to win the heart of the princess. He rose up, pulled a dagger from his sheath, and stabbed himself in the heart.  (Remaining in the flower is a heart shape with the stamen, appearing as a dark green line down the center. Hold the heart up, carefully remove the dagger-like line, and plunge the dagger through the heart.) The princess was overcome by the dedication of the dying prince and his unending love for her. She realized too late that she loved him also. “Alas,” she cried out. “I have done wrong. My own heart is also broken. I shall bleed for my prince forevermore!” And her heart bleeds to this very day.”   May 14, 1946 On this day, Paul Hindemith's composition When Lilacs Last in the Door-Yard Bloom'd: A Requiem «For Those We Love»  premiered. The music was inspired by a poem of the same title by Walt Whitman, When Lilacs Last in the Door-Yard Bloom'd. Walt Whitman wrote his poem in the summer of 1865. The country was still mourning the assassination of President Lincoln. In 206 lines, Walt does not mention Lincoln’s name or the assassination. Instead, he uses nature and nature imagery to move the reader from grief to acceptance. Lincoln was killed in the springtime - on April 14, 1865. Walt was at his mother’s home when he heard the news. Later he recalled, “I remember… there were many lilacs in full bloom… I find myself always reminded of the great tragedy of that day by the sight and odor of these blossoms. It never fails.” When Walt Whitman was 54 years old, he suffered a stroke that left him paralyzed. He spent the next two years immersed in nature, and he believed that nature had helped heal him. He wrote, "How it all nourishes, lulls me, in the way most needed; the open air, the rye-fields, the apple orchards.”   Unearthed Words But spring twilight found her barefoot in the garden, planting beans and helping me fill my pail with earthworms that were severed by her shovel. I thought I could nurse them back to health in the worm hospital I constructed beneath the irises. She encouraged me in this, always saying, “There is no hurt that can’t be healed by love.” ― Robin Wall Kimmerer, mother, plant ecologist, writer, and SUNY Distinguished Teaching Professor, Braiding Sweetgrass: Indigenous Wisdom, Scientific Knowledge and the Teachings of Plants   Grow That Garden Library Nature into Art by Thomas Christopher This book came out in 2019, and the subtitle is The Gardens of Wave Hill. In this book, Thomas introduces us to Wave Hill - a garden that opened to the public in 1967. A public garden in the Bronx, Wave Hill is known for its daring and innovative horticulture. Thomas takes us on a tour of the different areas of the garden — the flower garden, wild garden, shade border, and conservatory. In addition, Thomas reviews the plants and design principles that underpin Wave Hill. Enchanting and inspiring, Wave Hill manages to delight and instruct gardeners all year long. This book is 296 pages of a private tour of a jewel of the Bronx - the iconic Wave Hill. You can get a copy of Nature into Art by Thomas Christopher and support the show using the Amazon Link in today's Show Notes for around $3   Today’s Botanic Spark Reviving the little botanic spark in your heart May 14, 1846 Today is the anniversary of the death of the American scientist, horticulturist, and physician James Mease. A son of Philadelphia, James was a passionate gardener, and he consistently referred to tomatoes the way the French did - as “Love Apples.” In 1812, James published the first known tomato-based ketchup recipe. Although Ketchup had existed in China for centuries, James added the tomato base - something that caught on not only in the United States but also in England. For his unique recipe, James used tomato pulp, spices, and brandy. Unlike many other recipes, James did not use sugar or vinegar. He named his recipe “Love-Apple Catsup."   Thanks for listening to The Daily Gardener. And remember: "For a happy, healthy life, garden every day."

Relay Iowa has been called the longest relay in the world. Each June, teams of up to 12 gather in Sioux City to make the 339-mile trek over three days and two nights to Dubuque. After being canceled for the first time in 2020 due to the pandemic, race organizers made the difficult decision to forge ahead this year with fewer teams and more safety precautions. The event has raised more than $100,000 for Restoring Hope Village, a group of homes for orphaned children in South Africa, as well as several Iowa-based charities. Covering challenging and beautiful terrain over 339 miles, Relay Iowa truly is the RAGBRAI of running. Listen to hear more. Apologies for some audio issues during the podcast. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/lance-bergeson8/support

This week, we sat down with Philip J. Mease, MD, to discuss his study, “Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.”

Go online to PeerView.com/HYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses treatment with IL-17 inhibitors in nonradiographic axial spondyloarthritis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), Discuss the rationale for IL-17 inhibition as a treatment approach to axSpA, Summarize efficacy and safety data related to IL-17 inhibitors for the treatment of nr-axSpA, Apply anti-IL-17 therapy for the treatment of nr-axSpA in accordance with current evidence and individual patient needs.

Go online to PeerView.com/HYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses treatment with IL-17 inhibitors in nonradiographic axial spondyloarthritis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), Discuss the rationale for IL-17 inhibition as a treatment approach to axSpA, Summarize efficacy and safety data related to IL-17 inhibitors for the treatment of nr-axSpA, Apply anti-IL-17 therapy for the treatment of nr-axSpA in accordance with current evidence and individual patient needs.

Go online to PeerView.com/HYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses treatment with IL-17 inhibitors in nonradiographic axial spondyloarthritis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), Discuss the rationale for IL-17 inhibition as a treatment approach to axSpA, Summarize efficacy and safety data related to IL-17 inhibitors for the treatment of nr-axSpA, Apply anti-IL-17 therapy for the treatment of nr-axSpA in accordance with current evidence and individual patient needs.

Go online to PeerView.com/HYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses treatment with IL-17 inhibitors in nonradiographic axial spondyloarthritis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), Discuss the rationale for IL-17 inhibition as a treatment approach to axSpA, Summarize efficacy and safety data related to IL-17 inhibitors for the treatment of nr-axSpA, Apply anti-IL-17 therapy for the treatment of nr-axSpA in accordance with current evidence and individual patient needs.

Go online to PeerView.com/HYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses treatment with IL-17 inhibitors in nonradiographic axial spondyloarthritis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), Discuss the rationale for IL-17 inhibition as a treatment approach to axSpA, Summarize efficacy and safety data related to IL-17 inhibitors for the treatment of nr-axSpA, Apply anti-IL-17 therapy for the treatment of nr-axSpA in accordance with current evidence and individual patient needs.

Go online to PeerView.com/HYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses treatment with IL-17 inhibitors in nonradiographic axial spondyloarthritis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), Discuss the rationale for IL-17 inhibition as a treatment approach to axSpA, Summarize efficacy and safety data related to IL-17 inhibitors for the treatment of nr-axSpA, Apply anti-IL-17 therapy for the treatment of nr-axSpA in accordance with current evidence and individual patient needs.

Host: Christopher T. Ritchlin, MD, MPH Guest: Atul A. Deodhar, MD, MRCP Guest: Philip J. Mease, MD Guest: Alexis Ogdie, MD, MSCE Can you put the puzzle together in axial spondyloarthritis (axSpA) and axial psoriatic arthritis (axPsA)? Axial involvement is an important feature in patients with SpA and PsA, and this manifestation has various similarities and differences between both diseases.1,2 Recognizing and assessing the unique presentation of axPsA and axSpA is critical to improve the outcomes in our patients. Listen in to a discussion panel moderated by Christopher T. Ritchlin, MD with Atul Deodhar, MD, Philip Mease, MD, and Alexis Ogdie-Beatty, MD, as they discuss current diagnostic challenges and new insights on the assessment of axial features. This presentation is sponsored by Novartis Medical Affairs and all speakers have been compensated for their time. References Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: A critical comparison. Nat Rev Rheumatol. 2018;14(6):363-371. doi:10.1038/s41584-018-0006-8 Helliwell PS. Axial disease in psoriatic arthritis. Rheumatology. 2019:1-3. doi:10.1093/rheumatology/kez629 3/21 M-XAT-1399851​

#021 Building Trust Within Your Department with Kara MeaseParaprofessionals must have knowledge and skills to support our students and they must be good at building relationships with children. Like other educators, a paraprofessional needs to know when to step back and encourage a student to be independent, but also when to step in and provide assistance. Paras must have good time management skills and be able to take direction.But there’s something else paraprofessionals must have...trust.In today's episode we hear from Kara Mease who has been a paraprofessional with my department for 3 years. She shares what my co-teacher and I did to set her up for success from day 1 using this paraprofessional handbook and stresses the importance of being able to trust her supervisors and the desire to have them trust her.If building trust within your department has been one of the blindspots you’ve been missing, then I hope this episode has hit home with you.Speaking of blindspots...make sure you take the Special Educator's Superpower Quiz to get affirmation of the things you do well as a teacher and the blindspots that are holding you up from becoming the teacher you always dreamed you’d be. And who knows...you might get Batman like me which is just pretty cool! Go to spedprepacademy.com/quiz to find out your superpower.You can check out the show notes at www.spedprepacademy.com/podcast

Han sido muchos meses desde que nos escuchamos la última vez. En este episodio, hablaré de la evidencia que hay sobre riesgo de tromboembolismo venoso en pacientes que usan inhibidores de JAK.Estas son algunas referencias revisadas para este episodio.Les agradezco su continuado apoyo y su paciencia. Por favor difundan este podcast entre sus conocidos. Choi, H. K. et al. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann. Rheum. Dis. 72, 1182–1187 (2013).Cohen, S. B. et al. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2020-218510 (2020).Genovese, M. et al. Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis. Lancet Rheumatol. 2, E347–E357 (2020).Mease, P. et al. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. Ann. Rheum. Dis. 79, 1400–1413 (2020).Molander, V., Bower, H. & Askling, J. Does the risk of venous thromboembolism vary with disease activity in rheumatoid arthritis? [abstract]. Ann. Rheum. Dis. 79 (Suppl. 1), 23–24 (2020).Sandborn, W. J. et al. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Aliment. Pharmacol. Ther. 50, 1068–1076 (2019).Samuelson, B. T. et al. The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis. Blood Coagul. Fibrinolysis 27, 648–652 (2016).Yates, M. et al. Venous thromboembolism risk with JAK inhibitors: a meta-analysis. Arthritis Rheumatol. https://doi.org/10.1002/art.41580 (2020).Winthrop, K. L. The emerging safety profile of JAK inhibitors in rheumatic disease. Nat. Rev. Rheumatol. 13, 234–243 (2017).Winthrop, K. et al. Integrated safety of filgotinib in patients with moderately or severely active rheumatoid arthritis receiving treatment for up to 5.5 years [abstract]. Arthritis Rheumatol. 72 (Suppl. 10), 229 (2020).

Professor Philip Mease from the University of Washington School of Medicine. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor Philip Mease discusses his latest paper on Upadacitinib for Psoriatic Arthritis refractory to biologics.

Host: John J. Russell, MD Guest: Philip J. Mease, MD Guest: April Armstrong, MD, MPH Of the more than eight million Americans living with psoriasis, up to 30 percent of them may go on to develop psoriatic arthritis (PsA). Dr. Philip Mease and Dr. April Armstrong are here to walk us through how physicians can provide multidisciplinary care for people living with this chronic condition. We’ll also hear from them about a treatment option available to adults with active PsA. This promotional educational activity is brought to you by Janssen Pharmaceuticals, Inc., and is not certified for continuing medical education. The consultants are paid speakers for Janssen Pharmaceuticals, Inc. The speakers are presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen. © Janssen Pharmaceuticals, Inc. 2020 12/20 cp-187500v1

Cutting Our Teeth. One of Europe's most important labels, Hassle Records, are our guests on Episode 94 of Sappenin' Podcast! As the record label celebrates its 15th year anniversary, founder Wez and project manager Mease join us for a chance to pick their brains about our favourite releases and a round table dissuasion about what really goes on behind the scenes. Hear about their involvement with bands like Alkaline Trio, We Are The Ocean, Frank Iero, Canterbury, Alexisonfire, Cancer Bats, Lonely The Brave, Casey, Four Year Strong and more to what life is really like as an independent label, industry secrets, advice for upcoming bands, signing Juliet And The Licks when everything started, why some of our favourite bands didn't quite make it, the evolution of steaming, PR, their current roster, what they look for in an artist, their celebratory 15x15 vinyl re-issues series, the future and a lot more including the ONE band that got away. Trust us, you'll be flabbergasted. This was super interesting to do, we learned a lot and it was really cool seeing how this aspect of the music actually works. I hope you enjoy it as much as we did. Turn it up and join Sean and Morgan to find out Sappenin' this week!Follow Us on Social Media:Twitter: @sappeninpod.Instagram: @sappeninpod.Limited Edition Sappenin' Podcast merch: sappenin-podcast.myshopify.com. Special thank you to our Sappenin' Podcast Patreons:Join the Sappenin' Podcast Community: Patreon.com/Sappenin.Kylie Wheeler, Mayumi Liwayway, Emma Barber, Mitch Perry, Shani-Maia Boxill-Anderson, Dayna Lasnover, Amandine Urbano, Janelle Caston, Drew Styles, Samantha Spray, Dilly Grimwood, Nathan Crawshaw, Kelly Young, Kelly Irwin, Johnny Phillips, Scarlet Charlton, Simon Amos, Jenni Munster, Cate Stevenson, Amy Campion, Emily Senogles, Lucy Deards, Martina McManus, Erin Howard, John&Emma, James Oakley, Louis Cook, Marcie Jacobson, Kieran Lewis, Jordan Birchard, Mike Cunningham, Jamie O'Jaime, Paddy The Magnificent, Carl Pendlebury, Kelly Emma Cannon, Livvy Cropper, Paul Hirschfield, Becky Magliocco, James McNaught, Lydia Henderson, Ricky McClurg, Amy Thomas, Scott Jones, Tallulah Grant, Stuart McNaught, Tony Michael, Jenni Robinson, Jamie Bloor, Sarah James, Michael Engler, El Douglas, Mark Hendy, Loz Sanchez, Natasha Morris, Kelly Mallery, James Bowerbank, Mikey White, Becky Handy, Kevin Clarke, Jean Davies, Cerys Andrews, Let it Flow Yoga, Rhys Bernardo, Samuel Griffiths, Liam Connolly, Jordan Harris, Kyle David Smith, James Page, Kat Bessant, Justin Dunn, Samantha Neville, Ash Foster, Gabby Byrne, Nora Pickler, Chris Harris, Sophie Thompson, Scott Evans, Geoff Halbherr, Danny Eaton, Jessie Hellier, Neil Reid, Emily Dixon, David Winchurch, Kelly Tyrer, Hannah Rachael, Justine Baddeley, Anthony Matthews, Nuala Clark, Owen Davies, Angharad Richards, Samantha Bowen, Sandra Kucharczyk, Gavin Butler, Jennifer Dean, Ryan Woodman, Matt Roberts, Robert Pike, Robert Byrne, Hannah Talbot, Ida Christensen, Nicola Johnson, Rebecca Harrison, Luke Wardle, Sarah Maher, Alanágh Nic Gabhann, Lewis Sluman, Andy Saxton, Snowdogg7, Helen Macbethm, Callum Oakshott, Emma Forni, Adam Tibbs, Alice Boyns, Joshua... See acast.com/privacy for privacy and opt-out information.

On Thursday, October 8, 2020, Planters of Morton Plant Mease Health Care Foundation will host their Virtual Fall Luncheon, honoring this year's Lois Odence Nursing Scholarships Recipients. Make your reservation here: https://bit.ly/2QpsQe0

In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF guidelines for the management of psoriatic arthritis, together with key clinical trials that have been published since the guidelines were released. Listen to part 1 here Find more on Medicine Matters rheumatology

Lead investigator Philip Mease outlines the results of the DISCOVER-2 trial, and discusses how guselkumab may impact the psoriatic arthritis treatment landscape. Find more on Medicine Matters rheumatology More from the 2019 ACR/ARP Annual Meeting

Sermon Slides (Click on the sermon above to access the slides)

In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines. Find more on Medicine Matters rheumatology Image credits: © tashatuvango/Fotolia

¡Gracias por escuchar! En este episodio repaso algunos conceptos relevantes sobre la dactilítis, una manifestación común en espondiloartritis. Les pido amablemente que califiquen este episodio en iTunes, o dejen sus comentarios en esta página. El podcast se encuentra disponible también en Spotify y a través de la aplicación gestora de podcasts de su elección.Abajo enlisto referencias útiles, algunas mencionadas en el episodio: Olivieri, I., Scarano, E., Padula, A., Giasi, V. & Priolo, F. Dactylitis, a term for different digit diseases. Scand. J. Rheumatol. 35, 333–340 (2006). Gladman, D. D., Ziouzina, O., Thavaneswaran, A. & Chandran, V. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. J. Rheumatol. 40, 1357–1359 (2013). Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N. Engl. J. Med. 376, 957–970 (2017). Rothschild, B. M., Pingitore, C. & Eaton, M. Dactylitis: implications for clinical practice. Semin. Arthritis Rheum. 28, 41–47 (1998). Taylor, W. J. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 54, 2665–2673 (2006). Rudwaleit, M. et al. The Assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25–31 (2011). Brockbank, J. E., Stein, M., Schentag, C. T. & Gladman, D. D. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann. Rheum. Dis. 64, 188–190 (2005). Kavanaugh, A., Helliwell, P. & Ritchlin, C. T. Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Rheumatol. Ther. 3, 91–102 (2016). Kaeley, G. S., Eder, L., Aydin, S. Z., Gutierrez, M. & Bakewell, C. Dactylitis: a hallmark of psoriatic arthritis. Semin. Arthritis Rheum. 48, 263–273 (2018). McGonagle, D., Conaghan Philip, G. & Emery, P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 42, 1080–1086 (2001). Tinazzi, I. et al. ‘Deep Koebner’ phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis. Ann. Rheum. Dis. 77, 922 (2018). Pattison, E., Harrison, B. J., Griffiths, C. E., Silman, A. J. & Bruce, I. N. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann. Rheum. Dis. 67, 672–676 (2008). Ng, J., Tan, A. L. & McGonagle, D. Unifocal psoriatic arthritis development in identical twins following site specific injury: evidence supporting biomechanical triggering events in genetically susceptible hosts. Ann. Rheum. Dis. 74, 948–949 (2015). Jacques, P. et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann. Rheum. Dis. 73, 437–445 (2014). Jacques, P. & McGonagle, D. The role of mechanical stress in the pathogenesis of spondyloarthritis and how to combat it. Best Pract. Res. Clin. Rheumatol. 28, 703–710 (2014). Thorarensen, S. M. et al. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann. Rheum. Dis. 76, 521–525 (2017). Wilkins, R. A., Siddle, H. J., Redmond, A. C. & Helliwell, P. S. Plantar forefoot pressures in psoriatic arthritis-related dactylitis: an exploratory study. Clin. Rheumatol. 35, 2333–2338 (2016). Tan, A. L. & McGonagle, D. The need for biological outcomes for biological drugs in psoriatic arthritis. J. Rheumatol. 43, 3–6 (2016). Mumtaz, A. et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann. Rheum. Dis. 70, 272–277 (2011). Helliwell, P. S. et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann. Rheum. Dis. 72, 986–991 (2013). Ramiro, S., Smolen, J. S., Landewe, R., van der Heijde, D. & Gossec, L. How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review. Ann. Rheum. Dis. 77, 782–783 (2017). Salvarani, C. et al. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J. Rheumatol. 28, 2274–2282 (2001). Antoni, C. E. et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum. 52, 1227–1236 (2005). Clegg, D. O. et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 39, 2013–2020 (1996). Helliwell, P. S. et al. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J. Rheumatol. 32, 1745–1750 (2005). Healy, P. J. & Helliwell, P. S. Measuring dactylitis in clinical trials: which is the best instrument to use? J. Rheumatol. 34, 1302–1306 (2007). Chandran, V. et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum. 61, 1235–1242 (2009).Mease, P. et al. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann. Rheum. Dis. 73, 48–55 (2014). Fournie, B. et al. Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler study versus rheumatoid arthritis. Joint Bone Spine 73, 527–531 (2006). Benjamin, M. & McGonagle, D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J. Anat. 199, 503–526 (2001). Kane, D., Greaney, T., Bresnihan, B., Gibney, R. & FitzGerald, O. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J. Rheumatol. 26, 1746–1751 (1999). Tinazzi, I. et al. Comprehensive evaluation of finger flexor tendon entheseal soft tissue and bone changes by ultrasound can differentiate psoriatic arthritis and rheumatoid arthritis. Clin. Exp. Rheumatol. 36, 785–790 (2018). McGonagle, D., Gibbon, W. & Emery, P. Classification of inflammatory arthritis by enthesitis. Lancet 352, 1137–1140 (1998). Olivieri, I. et al. Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum. 39, 1524–1528 (1996).Olivieri, I. et al. Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J. Rheumatol. 24, 926–930 (1997). Olivieri, I. et al. Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum. 46, 2964–2967 (2002). Healy, P. J., Groves, C., Chandramohan, M. & Helliwell, P. S. MRI changes in psoriatic dactylitis extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology 47, 92–95 (2008). Tan, A. L. et al. High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Ann. Rheum. Dis. 74, 185–189 (2015). FitzGerald, O., Haroon, M., Giles, J. T. & Winchester, R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res. Ther. 17, 115 (2015). McHugh, K. & Bowness, P. The link between HLA-B27 and SpA—new ideas on an old problem. Rheumatology 51, 1529–1539 (2012). Ritchlin, C. T. et al. Treatment recommendations for psoriatic arthritis. Ann. Rheum. Dis. 68, 1387–1394 (2009). Coates, L. C. et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheum. 68, 1060–1071 (2016). Gossec, L. et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann. Rheum. Dis. 75, 499–510 (2016). Coates, L. & Helliwell, P. S. Methotrexate efficacy in the Tight Control in Psoriatic Arthritis study. J. Rheum. 43, 356–361 (2016). Rose, S., Toloza, S., Bautista-Molano, W. & Helliwell, P. S. Comprehensive treatment of dactylitis in psoriatic arthritis. J. Rheumatol. 41, 2295–2300 (2014). Kavanaugh, A. et al. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2). Ann. Rheum. Dis. 75, 1984–1988 (2016). Mease, P. et al. Tofacitinib or adalimumab versus placebo for psoriatic arthritis. N. Engl. J. Med. 377, 1537–1550 (2017). Kavanaugh, A. et al. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum. 64, 2504–2517 (2012). Kavanaugh, A. & Mease, P. Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL). J. Rheumatol. Suppl. 89, 90–93 (2012). Antoni, C. E. et al. Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). J. Rheumatol. 35, 869–876 (2008). Kavanaugh, A. et al. Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Ann. Rheum. Dis. 66, 498–505 (2007). Baranauskaite, A. et al. Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study. Ann. Rheum. Dis. 71, 541–548 (2012). Carron, P. et al. Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis. RMD Open 2, e000265 (2016). Nash, P. et al. Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3). Arthritis Res. Ther. 20, 47 (2018). Mease, P. et al. Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study. Ann. Rheum. Dis. 77, 890–897 (2018). Mease, P. J. et al. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann. Rheum. Dis. 76, 79–87 (2017). Wells, A. F. et al. Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial. Rheumatology 57, 1253–1263 (2018). Gladman, D. et al. Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors. N. Engl. J. Med. 377, 1525–1536 (2017). Mease, P. J. et al. Efficacy and safety of abatacept, a T cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis. Ann. Rheum. Dis. 76, 1550–1558 (2017). Genovese Mark, C. et al. Apremilast in patients with active rheumatoid arthritis: a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum. 67, 1703–1710 (2015). Smolen, J. S. et al. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Ann. Rheum. Dis. 76, 831–839 (2017). Kavanaugh, A. et al. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann. Rheum. Dis. 73, 1020–1026 (2014). Kunwar, S., Dahal, K. & Sharma, S. Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatol. Int. 36, 1065–1075 (2016). da Silva Junior, G. B., Daher Ede, F. & da Rocha, F. A. Osteoarticular involvement in sickle cell disease. Rev. Bras. Hematol. Hemoter. 34, 156–164 (2012). Braum, L. S. et al. Characterisation of hand small joints arthropathy using high-resolution MRI — limited discrimination between osteoarthritis and psoriatic arthritis. Eur. Radiol. 23, 1686–1693 (2013). Tan, A. L., Grainger, A. J., Tanner, S. F., Emery, P. & McGonagle, D. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum. 54, 1328–1333 (2006). Tuttle, K. S., Vargas, S. O., Callahan, M. J., Bae, D. S. & Nigrovic, P. A. Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity. Pediatr. Rheumatol. Online J. 13, 7 (2015). Nash, P. et al. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. Lancet 389, 2317–2327 (2017).Jeong, H. et al. Spondyloarthritis features in zymosan-induced SKG mice. Joint Bone Spine 85, 583–591 (2018). 

Welcome to season 3 of Word Bros! Caleb and Noah are awesome dudes. They are promoting there Kickstarter A Small[...]

Two English teachers sit down to discuss one of the most famous American short stories, "The Lottery" by Shirley Jackson. Covering everything from how the summer day makes human sacrifice that much better, is Tessie Hutchinson a good mother (no) and some themes developed from the text, Mr. LaRue and Ms. Mease from North Tama High School dissect the text and make it easier for you to understand.

Philip J. Mease, MD, from Swedish Medical Center, discusses results from the phase 4 SPIRIT-H2H clinical trial that compared the safety and efficacy of ixekizumab—an interleukin-17a monoclonal antibody—with adalimumab—a tumor necrosis factor inhibitor—for psoriatic arthritis. For more content, visit consultant360.com/rheumatology.

Join us this week with our first guest on the Liquor Store Podcast, Jeff Mease, Founder of Bloomington Brewing Company, Pizza X and Lennie's.  http://www.bloomingtonbrew.com/ https://www.pizzaxbloomington.com/ https://www.lenniesbloomington.com/ https://bigredliquors.com/

Dr Mease reviews the pathogenesis of PsA and the role of IL-17 inhibitors in the treatment of PsA through an examination of clinical data. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/917881?src=mkm_podcast_addon_917881

Philip J. Mease, MD, from Swedish Medical Center, discusses results from a phase 2 clinical trial on tildrakizumab—an anti-interleukin-23p19 monoclonal antibody—and its potential as a therapeutic option for psoriatic arthritis.

Lead investigator Philip Mease outlines the results of a phase IIb trial supporting further development of the anti-interleukin-23p19 monoclonal antibody tildrakizumab for the treatment of psoriatic arthritis. Find more on Medicine Matters rheumatology This content was originally published on Medicine Matters rheumatology (https://rheumatology.medicinematters.com/) on June 12, 2019.

Lead investigator Philip Mease discusses the findings from the SPIRIT-H2H trial, a phase III head-to-head trial of ixekizumab versus adalimumab in patients with psoriatic arthritis. Find more on Medicine Matters rheumatology This content was originally published on Medicine Matters rheumatology (https://rheumatology.medicinematters.com/) on June 15, 2019.

In this episode, we continue our investigation of the Great Plains Bison with a visit to 777 Bison Ranch near Rapid City, South Dakota.  Owner Mimi Hilenbrandt and fellow operations manager Moritz Espy gave us a tour of the pastures and corrals.  Along the way, we discussed differences and similarities between bison and cattle, the possibility of a buffalo commons, their business model and how it affects the bison, and how their decades of Holistic Management and bison grazing have led to regeneration of the prairie landscape.  We also discussed a few of the complex questions the bison forces us to wrestle with. You can find them at In the episode I refer to a book about restoration bison ranching.  It's called A Wild Idea, by Dan O'brien of Wild Idea Buffalo Company, whom you'll hear from next episode. Michael DiGiorgio recorded the banjo-bird jams I'm using in the intro and ending. You can find his amazing nature art at . Mike says that if you'd like to buy the album of his nature-banjo jams, you can find his email on his website and he can mail you a CD.  

One World Enterprises Owner Jeff Meade joins us live from Bloomington, Indiana!

We rupture the infamous "fourth wall" of theatre, going behind the scenes with Rob Neill '91, founding member of the New York Neo Futurists, to discuss their unique brand of performance, which lies somewhere between improv, sketch comedy, and avant-garde theatre. We also talk with Ellen Mease about the more traditional theatrical world of Shakespeare's Twelfth Night, which Mease directed this semester. She shares what Grinnell's theatre has meant to her, 40 years after she first directed her first production of the show.

This episode of Muse Ecology is the first in this four part series beginning to explore humankind's relation to the bison in the Great Plains of North America. This buffalo series features diverse voices of folks involved in the bison's return that Alison and I met on our buffalo investigation journey in February 2018. While the next three episodes feature entrepreneurs and ranchers who are working to restore bison to the landscape, this first episode features voices of wildlife advocates who see the buffalo as a wild elder whose right to roam long precedes our recent human constructs.   The first visit on our buffalo journey was with the Buffalo Field Campaign, a volunteer-run organization that exists to defend the dignity and freedom of the last continuously wild herd of buffalo in North America, in Yellowstone National Park. Founded over 20 years ago by Lakota Grandmother Rosalie Littlethunder and videographer Mike Mease, through documentation and advocacy, the BFC seeks to promote awareness of the story and management of the Yellowstone bison, and to influence policy to allow them to roam free like the other wild ones.   At just over two and a half hours this episode ended up a bit long, but felt like one story to be released together, so I divided it up into chapters like an audio book or radio play, and created a table of contents with minute and second, to make it easy to restart if you have to take a break.   00:00:52         Introduction to the Buffalo Series 00:09:17         Arrival at BFC 00:09:46   Chapter 1: The First Annual Rosalie Littlethunder Memorial                                   Walk 00:15:44   Rosalie Memorial Circle 00:29:27   Chapter 2: Buffalo Awareness in Bozeman 00:29:31        More Words From Karen Littlethunder and Cheryl Angel 00:35:04        Awareness Rally Grooves 00:38:53   Chapter 3: Ski Patrol and Share Frog 00:38:55        A Daily Meeting 00:45:55        Buffalo Patrol 00:52:96        A Wild Lullaby for Share Frog 00:57:05   Chapter 4: Jimmy Brings an Important Message 01:09:46   Chapter 5: A Conversation with Stephanie Seay 01:11:24        Conversation with Stephanie 01:35:14   Chapter 6: A Conversation with Mike Mease 01:36:05        Details about the March webinar 01:36:46        Conversation with Mike 02:36:11        Closing Rumination and Introduction of Tanka Bar Episode   You can connect with the Buffalo Field Campaign, to follow their work or arrange to volunteer for a while, at Michael DiGiorgio recorded the banjo-bird jams I'm using in the intro and ending. You can find his amazing nature art at . Mike says that if you'd like to buy the album of his nature-banjo jams, you can find his email on his website and he can mail you a CD.  

Welcome to the Audible Café Podcast! Today, my guest is Mike Mease, Campaign Coordinator and Co-Founder of the Buffalo Field Campaign. The Buffalo Field Campaign is the only group working both in the field and in policy arenas to stop the harassment and slaughter of America’s last truly wild, genetically pure buffalo in America. These buffalo are the direct descendants of the 30 to 60 million buffalo that used to roam continental North America, and their herd currently contains less than 4,000 members. The primary goal of the Buffalo Field Campaign is to create permanent year-round protection for bison and the ecosystem they depend on—including respect for the migratory needs of this long-exploited and clearly endangered species. Mike has been devoted to the cause of the wild buffalo for over 22 years.  The fact that President Obama signed into law the National Bison Legacy Act, which designates the bison as the official mammal of the United States, has done nothing to protect the buffalo! The Act includes a disclaimer that the designation does not change the current management plan that is actually devastating the herd through bad management and what Mike and others aptly call “boxed hunts”.  Buffalo Field Campaign staff and volunteers are in the process of shepherding through the federal court a case for listing the wild buffalo as an endangered species that would give these wonderful animals the protections they need to thrive - that is, so long as the Endangered Species Act thrives - which is another battle we all must join in. Securing Endangered Species Act status is a long haul and the Buffalo Field Campaign team needs your help! They are halfway through an 8-year process for designating this mammal as an endangered species, and what should be a straightforward and swift action is nothing of the kind. With the herd down to less than 4,000 members, this is an urgent call to action. So after you listen to this great interview with Mike Mease of the Buffalo Field Campaign, please visit their website at buffalofieldcampaign,org and please take note of their matching campaign before it ends on November 30th. They are a transparent and hard-working non-profit, and they are one of a kind in the nation - the only ones doing this work on behalf of the herd. So also visit their “Get Involved” page to take action on behalf of the last wild herd of buffalo so dearly in need of our protection. The “About Buffalo” section of the website is truly awesome and full of inspiring information about buffalo. The whole website is great. Thanks again to Mike Mease of Buffalo Field Campaign for taking the time to share his passion for the buffalo and his important work on their behalf. And thank you so much for listening to Audible Café! As always, you can learn more and access archives and show notes with lots of resources at audiblecafe.com, or visit the FB page - just search for Audible Cafe, or follow us on Twitter @audiblecafe. If you listen on iTunes it would be great if you would review the podcast… 5 stars are OK with us!  And if you’d like to get directly in touch with us, email listenup@audiblecafe.com. Have a great day! RESOURCES Buffalo Field Campaign website:  buffalofieldcampaign.org Protect Our National Mammal: Be a Voice For the Buffalo! Educational Slideshow for sharing Get involved to save the herd! - Action opportunities CREDITS: Audible Café theme music by Brian Eddy

Ready for some practical, down-to-earth strategies to bring clarity and harmony back into your busy life? Energy practitioner and intuitive life advisor Cheyenne Mease comes to the rescue with guidance on handling difficult situations and reconnecting with your personal vision.

Ready for some practical, down-to-earth strategies to bring clarity and harmony back into your busy life? Energy practitioner and intuitive life advisor Cheyenne Mease comes to the rescue with guidance on handling difficult situations and reconnecting with your personal vision. Cheyenne Mease, known to some as Cheyenne Autumn Whitehorse, is the founder of Health Heart Soul LLC, and the author of Clarity, Wisdom, Harmony: Simple and Concise Tools for Living. She brings close to 30 years' experience as a respected energy practitioner, speaker, and intuitive life advisor. Find out more about Cheyenne and her work at cheyennemease.com.

Ready for some practical, down-to-earth strategies to bring clarity and harmony back into your busy life? Energy practitioner and intuitive life advisor Cheyenne Mease comes to the rescue with guidance on handling difficult situations and reconnecting with your personal vision. Cheyenne Mease, known to some as Cheyenne Autumn Whitehorse, is the founder of Health Heart Soul LLC, and the author of Clarity, Wisdom, Harmony: Simple and Concise Tools for Living. She brings close to 30 years' experience as a respected energy practitioner, speaker, and intuitive life advisor. Find out more about Cheyenne and her work at cheyennemease.com.

Today we are talking to Joe about how his career has developed over the past two decades and the challenges of leaving an industry where you're a known player and starting something new.

This was audio was recorded at the 2012 Summer conference in Seattle Washington